PRESENTATION TITLE

Mohs Micrographic Surgery with Immunohistochemistry for Melanoma: Advances in Margin Control and Clinical Outcomes

PRESENTER(S)
Justin J. Leitenberger, M.D.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Describe the principles of Mohs micrographic surgery with immunohistochemistry (IHC) for the treatment of melanoma and melanoma in situ.
• Compare margin control, recurrence rates, and clinical outcomes of Mohs micrographic surgery with IHC versus traditional wide local excision for melanoma.
• Recognize appropriate patient selection criteria and clinical scenarios in which Mohs surgery with IHC offers the greatest benefit.
• Discuss technical considerations, pitfalls, and strategies to optimize accuracy and efficiency when performing Mohs surgery with immunohistochemistry for melanoma.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.